For: | Diken AI, Diken OE, Hanedan O, Yılmaz S, Ecevit AN, Erol E, Yalçınkaya A. Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients. World J Transplant 2016; 6(1): 193-198 [PMID: 27011917 DOI: 10.5500/wjt.v6.i1.193] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v6/i1/193.htm |
Number | Citing Articles |
1 |
Crisostomo Barajas-Solano, Betsy Muñoz, Eduardo Chicano-Gálvez, Patricia Escobar, Enrique Mejía-Ospino. Discriminator for Cutaneous Leishmaniasis Using MALDI-MSI in a Murine Model. Journal of the American Society for Mass Spectrometry 2022; 33(6): 952 doi: 10.1021/jasms.2c00015
|
2 |
Peter Chin-Hong, Marcelo Radisic. Infectious Diseases in Solid-Organ Transplant Recipients. 2019; : 219 doi: 10.1007/978-3-030-15394-6_15
|
3 |
Tirajeh Saadatzadeh, Michael Angarone, Valentina Stosor. Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention. Current Opinion in Infectious Diseases 2024; 37(2): 121 doi: 10.1097/QCO.0000000000001002
|
4 |
Lin Lin, Yunan Gao, Xiaochen Hu, Jiabao Ouyang, Chunbo Liu. Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway. BMC Women's Health 2022; 22(1) doi: 10.1186/s12905-022-02078-1
|